VEGFA Antikörper (AA 27-232)
Kurzübersicht für VEGFA Antikörper (AA 27-232) (ABIN7567817)
Target
Alle VEGFA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 27-232
-
Verwendungszweck
- Anti-Human VEGFA Monoclonal Antibody (1A169)
-
Aufreinigung
- Protein G purified from mice ascites.
-
Reinheit
- >95 %
-
Immunogen
- E. coli - derived recombinant Human VEGFA (Ala27-Arg232).
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.4 mg/mL
-
Buffer
- PBS, pH 7.4, containing 0.05 % proclin300, 50 % glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C,-80 °C
-
Informationen zur Lagerung
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
-
-
- VEGFA (Vascular Endothelial Growth Factor A (VEGFA))
-
Andere Bezeichnung
- VEGFA
-
Hintergrund
- Vascular endothelial growth factor A,VPF,VEGFA,VEGF,Vascular permeability factor,VEGF-A,
-
Pathways
- RTK Signalweg, Glycosaminoglycan Metabolic Process, Regulation of Cell Size, Tube Formation, Signaling Events mediated by VEGFR1 and VEGFR2, Platelet-derived growth Factor Receptor Signaling, VEGFR1 Specific Signals, VEGF Signaling
Target
-